Astragaloside IV
Astragaloside IV (Huang Qi Extract) · also known as Astragaloside IV, Astragaloside IV, Astragaloside IV
Astragaloside IV is a cycloartane-type triterpene saponin found in astragalus. Animal studies show it can affect Nrf2/HO-1, eNOS and intestinal tight junction markers, but it has not been confirmed that these pathways are activated in humans.
Mechanisms of action
Nrf2/ARE activation of endogenous antioxidant enzymes
In a rat model of renal ischemia-reperfusion, Nrf2 and HO-1 expression in kidney tissue increased after astragaloside IV treatment. Keap1-related effects and a several-fold induction of HO-1 have not been confirmed in humans, and it is also uncertain whether 20–50 mg/day reaches effective concentrations in human tissues.
Endothelial nitric oxide synthase (eNOS) coupling and NO vasodilation
Animal experiments show astragaloside IV can change eNOS phosphorylation and nitric oxide production, and related markers in kidney tissue also improved in diabetic rats. The claim that BH4 stabilizes eNOS coupling and prevents uncoupling has not been directly verified in humans at usual doses.
Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair
In an animal colitis model, colonic tight junction markers such as ZO-1 and Occludin improved after oral astragaloside IV. The doses in this model were relatively high, so it cannot be assumed that the dose used here is effective in humans.
Safety and drug interactions
Immune stimulation
Has immunomodulating effects. Each of these stimulates immune responses. They may counteract immunosuppressant drugs, and caution is also needed during active autoimmune disease.